T Cell Leukemia Lymphoma Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H12). Contributions are tax-deductible.
Po Box 22418, Seattle, WA 98122-0418
Among the 17 scored medical research organizations in Seattle, T Cell Leukemia Lymphoma Foundation holds 8.3 months of operating reserves (peer median 5.5 months), runs a typical yearly deficit of 11.5% (peers: surplus of 1.3%), and has cut spending 23.6% a year (peers: grown spending 3.8% a year).
In fiscal year 2023 it reported $9,135 in revenue and $9,396 in expenses, with contributions making up 100.0% of revenue.
Peers: the 17 Seattle medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$9,135Fiscal year 2023
Expenses$9,396Fiscal year 2023
Total assets$6,480Fiscal year 2023
Total liabilities$0Fiscal year 2023
Fiscal year ending December2023
Revenue$9,135
Expenses$9,396
Net income−$261
Net assets$6,480
Notable sources of revenue
Percent of total revenue
Contributions
$9,135
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$6,480
Total liabilities
$0
Net assets
$6,480
Compensation
Officers and key employees
$0
Share of expenses
0.0%
Fiscal year ending December2022
Revenue$9,825
Expenses$12,303
Net income−$2,478
Net assets$6,721
Notable sources of revenue
Percent of total revenue
Contributions
$9,825
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$6,721
Total liabilities
$0
Net assets
$6,721
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?